Overall Technical outlook

Price Summary

A 4.06% increase in Gland Pharma Limited's stock marked an stellar day on the market.
Gland Pharma Limited's stock began trading at 1894.0 on 2025-07-16, soared to 2006.4, dipped to 1891.0, and finished the day 4.06% up at 1970.9, with 1473919 shares exchanged.
The peak price for the stock in the past 52 weeks is 2141.6, with the lowest price being 1392.8.
Based on recommendations from 12 analysts, the future price of GLAND is expected to range from 1162.0 to 3120.0, with an average price expectation around 1677.6666.

Technicals


Aroon: Aroon's bullish trend persists, with Aroon Up staying at the 100 level. This indicates strong market momentum, but further analysis using additional indicators is necessary to determine the trend's sustainability and future direction.
GLAND aroon 98ba79
Aroon chart for Gland Pharma Limited


Bol. Bands: In its latest move, the current price has crossed over the upper Bollinger Band, indicating a bullish breakout. This movement suggests that buying pressure is intensifying, driving the price higher than expected. Traders may interpret this as a sign of strong market momentum, potentially leading to continued upward action for Gland Pharma Limited.
GLAND bbands 98ba79
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR continues its bullish outlook, reinforcing a crucial support level that may help sustain the current upward trend. This support suggests that the market is likely to continue climbing, with the bullish momentum remaining strong.
GLAND psar 98ba79
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The STOCHASTIC is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
GLAND stoch 98ba79
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend for Gland Pharma Limited, but the wavering slopes of the 20 and 50 SMAs indicate that this momentum may be weakening. This loss of strength could be a sign that the market is approaching a turning point, with the possibility of a bullish reversal on the horizon. Investors should watch for signs of a trend change as the current downtrend starts to fade.
GLAND trippleSMA 98ba79
Tripple SMA chart for Gland Pharma Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.